UCB (EBR:UCB) UCB Media Room: Disposal of own shares

Transparency directive : regulatory news

10/06/2022 20:00

https://mb.cision.com/Public/18595/3583705/96d275654f2fd9ba_800x800ar.png ** Disposal of own shares ------------------------------------------------------------ Brussels (Belgium), 10 June 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regulated= information=C2=A0 In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long-Term Incentive Program of the UCB= Group, as follows: https://mb.cision.com/Public/18595/3583705/81de9c48ac84b2e7_800x800ar.png In addition to these exercises, on 10 June 2022, in accordance with the ves= ting rules under its 2020 2021 and 2022 LTI plans, UCB SA/NV has delivered = for free a total of 1 490 UCB shares OTC to 6 members of the personnel of t= he Company and its subsidiaries. The highest independent bid price on Euron= ext Brussels on 10 June 2022 was =E2=82=AC 83.10. This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . For further information, contact UCB:=C2=A0 Investor Relations Antje Witte=C2=A0 T +32 2 559 94 14 antje.witte@ucb.com Corporate Communications Laurent Schots=C2=A0 T+32 2 559 92 64 laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 600 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi= llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news =C2=A0 GenericFile 220610 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1= 8595/3583705/82f8b137860d372d.pdf) GenericFile 220610 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/35= 83705/8d31d06d7336e38e.pdf) GenericFile 220610 - Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public= /18595/3583705/a561e74cbbe790fd.pdf) Image Chart 1 June 10 2022 (https://mb.cision.com/Public/18595/3583705/81de9c48ac= 84b2e7_org.png) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x108004x1x6868579x2400= 0x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium

UCB's latest news

17/04/2024 07:01

UCB (EBR:UCB) UCB Media Room: Disposal of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories